Plasma resistin, adiponectin, and risk of incident atrial fibrillation: The Framingham Offspring Study

American Heart Journal

Volumn 163, Issue 1, 2012, Pages

  Rienstra, Michiel ^a,b,c   Sun, Jenny X ^d   Lubitz, Steven A ^a   Frankel, David S ^e   Vasan, Ramachandran S ^c,f,g   Levy, Daniel ^c,h   Magnani, Jared W ^c,f   Sullivan, Lisa M ^d   Meigs, James B ^a,c   Ellinor, Patrick T ^a   Benjamin, Emelia J ^c,f,g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c FRAMINGHAM HEART STUDY   (United States)

^d BOSTON UNIVERSITY   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; RESISTIN;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 83555162500     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.09.029     Document Type: Article

References (37)

1. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125 (Pubitemid 44420743)
2. W.B. Kannel, P.A. Wolf, and E.J. Benjamin Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 1998 2N 9N (Pubitemid 28507114)
3. E.J. Benjamin, D. Levy, and S.M. Vaziri Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart study JAMA 271 1994 840 844
4. A.D. Krahn, J. Manfreda, and R.B. Tate The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study Am J Med 98 1995 476 484
5. B.M. Psaty, T.A. Manolio, and L.H. Kuller Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 1997 2455 2461 (Pubitemid 27425856)
6. T.J. Wang, H. Parise, and D. Levy Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477 (Pubitemid 39552671)
7. L. Frost, L.J. Hune, and P. Vestergaard Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish diet, cancer, and health study Am J Med 118 2005 489 495 (Pubitemid 40615472)
8. M.K. Chung, D.O. Martin, and D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891 (Pubitemid 33139098)
9. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010 (Pubitemid 37553570)
10. S. Cheng, M.J. Keyes, and M.G. Larson Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block JAMA 301 2009 2571 2577
11. M. Filkova, M. Haluzik, and S. Gay The role of resistin as a regulator of inflammation: Implications for various human pathologies Clin Immunol 133 2009 157 170
12. M. Kim, J.K. Oh, and S. Sakata Role of resistin in cardiac contractility and hypertrophy J Mol Cell Cardiol 45 2008 270 280
13. M. Karmazyn, D.M. Purdham, and V. Rajapurohitam Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart Cardiovasc Res 79 2008 279 286 (Pubitemid 351951616)
14. K. Azuma, F. Katsukawa, and S. Oguchi Correlation between serum resistin level and adiposity in obese individuals Obes Res 11 2003 997 1001 (Pubitemid 41137512)
15. D.S. Frankel, R.S. Vasan, and R.B. D'Agostino Sr Resistin, adiponectin, and risk of heart failure the Framingham Offspring study J Am Coll Cardiol 53 2009 754 762
16. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83 (Pubitemid 29299050)
17. N. Ouchi, S. Kihara, and T. Funahashi Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674 (Pubitemid 36222590)
18. R.S. Lindsay, T. Funahashi, and R.L. Hanson Adiponectin and development of type 2 diabetes in the Pima Indian population Lancet 360 2002 57 58 (Pubitemid 34756495)
19. T. Pischon, C.J. Girman, and G.S. Hotamisligil Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737 (Pubitemid 38489895)
20. C. Weikert, S. Westphal, and K. Berger Plasma resistin levels and risk of myocardial infarction and ischemic stroke J Clin Endocrinol Metab 93 2008 2647 2653 (Pubitemid 352008532)
21. J. Butler, A. Kalogeropoulos, and V. Georgiopoulou Serum resistin concentrations and risk of new onset heart failure in older persons: the health, aging, and body composition (Health ABC) study Arterioscler Thromb Vasc Biol 29 2009 1144 1149
22. M. Shimano, R. Shibata, and Y. Tsuji Circulating adiponectin levels in patients with atrial fibrillation Circ J 72 2008 1120 1124 (Pubitemid 351957078)
23. M. Feinleib, W.B. Kannel, and R.J. Garrison The Framingham Offspring study. Design and preliminary data Prev Med 4 1975 518 525
24. W.B. Kannel, M. Feinleib, and P.M. McNamara An investigation of coronary heart disease in families. The Framingham Offspring study Am J Epidemiol 110 1979 281 290 (Pubitemid 10204328)
25. K.K. Ho, K.M. Anderson, and W.B. Kannel Survival after the onset of congestive heart failure in Framingham Heart study subjects Circulation 88 1993 107 115 (Pubitemid 23195439)
26. R.B. Schnabel, L.M. Sullivan, and D. Levy Development of a risk score for atrial fibrillation (Framingham Heart study): a community-based cohort study Lancet 373 2009 739 745
27. T. Hastie, and R. Tibshirani Generalized additive models for medical research Stat Methods Med Res 4 1995 187 196
28. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J Am Coll Cardiol 50 2007 2021 2028 (Pubitemid 350087568)
29. M.P. Reilly, M. Lehrke, and M.L. Wolfe Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 2005 932 939 (Pubitemid 40279897)
30. C.M. Steppan, S.T. Bailey, and S. Bhat The hormone resistin links obesity to diabetes Nature 409 2001 307 312 (Pubitemid 32151228)
31. S. Verma, S.H. Li, and C.H. Wang Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction Circulation 108 2003 736 740 (Pubitemid 36999260)
32. P. Calabro, I. Samudio, and J.T. Willerson Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways Circulation 110 2004 3335 3340 (Pubitemid 39557496)
33. Y. Takata, H. Osawa, and M. Kurata Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes Hypertension 51 2008 534 539 (Pubitemid 351156444)
34. Y. Iwashima, T. Katsuya, and K. Ishikawa Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 43 2004 1318 1323 (Pubitemid 38691756)
35. M. Bajaj, S. Suraamornkul, and L.J. Hardies Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients Int J Obes Relat Metab Disord 28 2004 783 789 (Pubitemid 38746224)
36. M. Shimano, Y. Tsuji, and Y. Inden Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure Heart Rhythm 5 2008 451 459
37. R. Shibata, N. Ouchi, and M. Ito Adiponectin-mediated modulation of hypertrophic signals in the heart Nat Med 10 2004 1384 1389 (Pubitemid 40022722)